The prevalence of diabetic retinopathy is steadily increasing as the population of patients with diabetes grows. In the past decade, the development of anti-VEGF agents has dramatically changed the treatment landscape for diabetic retinopathy and diabetic macular edema (DME). Newer agents in development aim to reduce the treatment burden of diabetic retinopathy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ecl.2022.06.004 | DOI Listing |
Publication Analysis
Top Keywords
diabetic retinopathy
12
diabetic
5
future bright
4
bright advances
4
advances diabetic
4
diabetic eye
4
eye care?
4
care? prevalence
4
prevalence diabetic
4
retinopathy steadily
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!